Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Safety

Recall -- Firm Press Release

 

FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

 

American Regent, Inc. Initiates Voluntary Recall of Seventeen Lots of
Vasopressin Injection, USP, Multiple Dose Vials Due to Sub-Potency

 

Contact:
Consumer:
1-877-788-3232

Media:
Walter Tozzi, R.Ph., M.S., M.B.A.
Sr. Director of Professional Services
631-924-4000

FOR IMMEDIATE RELEASE - August 2, 2011 - Shirley, NY - American Regent, Inc. is conducting a nationwide voluntary recall of 5 lots of Vasopressin Injection, USP 20 units/mL (200 units/10mL), 10 mL Multiple Dose Vials; 11 lots of Vasopressin Injection, USP 20 units/mL, 1 mL Multiple Dose Vials; and 1 lot of Vasopressin Injection, USP 10 units/0.5 mL, 0.5 mL Multiple Dose Vials to the Retail/Hospital level. Recall of this product was initiated by American Regent, Inc. because some vials may not maintain potency throughout their shelf-life.

Potential adverse events after administration of solutions that are below potency limits may include reduced effectiveness. American Regent, Inc. has received no reports of adverse events related to reduced effectiveness for Vasopressin Injection, USP of the lots being recalled during the time period January 1, 2009 to July 27, 2011.

Vasopressin Injection, USP is indicated for prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows, and in diabetes insipidus.


Below are the product sizes and lots affected. The product was distributed to wholesalers and distributors nationwide.
 

Vasopressin Injection, USP 20 units/mL (200 units/10 mL), 10 mL multiple dose vial,
Package Size: 10, NDC # 0517-0410-10

Lot #Exp DateExp Period
9677October  201124 Months
0052January  201224 Months
0294October  201118 Months
0442December  201118 Months
0663April  201218 Months


Vasopressin Injection, USP 20 units/mL, 1 mL multiple dose vial,
Package Size: 25, NDC # 0517-1020-25

Lot #Exp DateExp Period
9532August 201124 Months
9618September 201124 Months
9707October 201124 months
0104February 201224 months
0124February 201224 months
0273October 201118 months
0346November 201118 months
0400December 201118 months
0437December 201118 months
0618March 201218 months
0758May 201218 months

 

Vasopressin Injection, USP 10 units/0.5 mL, 0.5 mL multiple dose vial
Package Size: 25, NDC # 0517-0510-25

Lot #Exp DateExp Period
0103February 201224 Months

Hospitals, infusion centers, clinics, retail pharmacies and other healthcare facilities should not use American Regent, Inc., Vasopressin Injection, USP Multiple Dose Vials with the lot #s listed above for patient care and should immediately quarantine any product for return to American Regent Inc.

American Regent, Inc. will credit accounts for all returned product with these lot #s. Those with questions about the return or recall process, please call our Customer Service Department at 1-877-788-3232: Monday thru Friday from 8:30 AM to 7:00 PM EDT.

Hospitals, infusion centers, clinics, retail pharmacies and other healthcare facilities with product quality complaints, medical or other questions concerning the use of the product or reasons for this recall should contact the Professional Services Department at 1-877-788-3232: Monday thru Friday from 9:00 AM to 5:00 PM EDT.

Any adverse reactions experienced with the use of this product should be reported to American Regent, Inc. via e-mail at pv@luitpold.com, by fax to (610) 650-0170, or by phone at 1-800-734-9236: Monday thru Friday from 9:00 AM to 5:00 PM EDT. TO EXPEDITE HANDLING, PLEASE DO NOT REPORT ANYTHING OTHER THAN SPECIFIC ADVERSE EVENTS TO THIS E-MAIL ADDRESS OR FAX OR PHONE.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail, or by fax.

· Online: www.fda.gov/medwatch/report.htm  

· Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.

· Fax: 1-800-FDA-0178.

This voluntary recall is being conducted with the knowledge of the U.S. Food & Drug Administration.

Vasopressin Injection, USP is manufactured by Luitpold Pharmaceuticals, Inc. and is distributed by American Regent, Inc. (Shirley, NY).

Source: Luitpold Pharmaceuticals, Inc.

 

 

###

RSS Feed for FDA Recalls Information [what's this?]

Photo: Product Labels

Recalled Product Photos Are Also Available on FDA's Flickr Photostream.